Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer - Liu, Chengming; Yang, Lu; Xu, Haiyan; Zheng, Sufei; Wang, Zhanyu; Wang, Sihui; Yang, Yaning; Zhang, Shuyang; Feng, Xiaoli; Sun, Nan; Wang, Yan; He, Jie (BMC medicine, 2022)
Keywords: Animal models; Antibiotics; Biomarkers; Cancer therapies; CD8 antigen; Clinical response; Cloning; Cytokines; IL-6; Immune checkpoint inhibitors; Immunology; Immunotherapy; Inflammation; Interleukin 6; Janus kinase; Lung cancer; Lymphocytes; Lymphocytes T; Macrophages; Medical research; Melanoma; Metastases; Non-small cell lung carcinoma; NSCLC; Patients; PD-L1 protein; Phenotypes; Plasma; Resistance; Small cell lung carcinoma; Stat3 protein; Suppressor cells; Tumor necrosis factor-TNF; Tumors; United Kingdom--UK; United States--US; China; Resistance; Immune checkpoint inhibitors; NSCLC; Clinical response; IL-6